Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Stomach Neoplasms 1 Renal Insufficiency 1 Prostatic Neoplasms 1 Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Breast Neoplasms 1

Interventions

Dexamethasone 7 Bortezomib 4 Lenalidomide 3 pomalidomide 2 glucarpidase 2 Kidney Transplantation 2 Bendamustine Hydrochloride 2 Azacitidine 2 vinflunine 1 trifluridine tipiracil drug combination 1 trebananib 1 safinamide 1 sacubitril and valsartan sodium hydrate drug combination 1 rubitecan 1 ripretinib 1 regorafenib 1 pevonedistat 1 osimertinib 1 mirabegron 1 gamma-Glutamyl Hydrolase 1 copanlisib 1 carfilzomib 1 Zoledronic Acid 1 Urinalysis 1 Topotecan 1 Thalidomide 1 Tablets 1 Stents 1 Sitagliptin Phosphate 1 Rituximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Renal Insufficiency × Urinalysis × Clear all

NCT04308642 2024-05-16

Kid-MaCareOnco

University Hospital, Basel, Switzerland

Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡